Kyle Kuvalanka
Signal active
Chief Financial Officer and Chief Business Officer
Contact Information
Social
Primary Organization
ROME Therapeutics
Founded
2020
Employees
11-50
Industry
Biotechnology, Health Care, Pharmaceutical
Bio
Kyle Kuvalanka is the Chief Financial Officer and Chief Business Officer of ROME Therapeutics. He previously worked at Goldfinch Bio as a Chief Financial and Operating Officer. Kyle Kuvalanka attended Wesleyan University.
Location
Cambridge, Massachusetts, United States, North America
Jobs history
3
ROME Therapeutics
Chief Financial Officer and Chief Business Officer
2023 - Current
Third Rock Ventures
Consultant
2018 - 2023
Goldfinch Biopharma
Chief Financial & Operating Officer
2020 - 2023
Educations
1
Wharton School of the University of Pennsylvania
Strategy, Finance
Profile Resume
Kyle Kuvalanka is the Chief Financial Officer and Chief Business Officer at ROME Therapeutics, based in United States, North America. With a background in Biotechnology, Kyle Kuvalanka has a rich history of leadership and innovation.Kyle Kuvalanka studied M.B.A. Strategy, Finance at Wharton School of the University of Pennsylvania. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.